Nurse-Patient Relations, Sleep Disorder, Therapeutic Adherence
Conditions
Brief summary
The aim of this study is to determine the effect of the therapeutic touch applied to the sleep patterns of individuals aged 65-85 years with chronic diseases who are treated in the Neurology Intensive Care Unit of Ankara City Hospital, taking into account the circadian cycle.The type of the research is the experimental model with pre-test and post-test control group.Ankara City Hospital has included the research population in the last year. It will consist of 1593 patients between the ages of 65-85 who are hospitalized in the Neurology Intensive Care Unit.Experimental and control groups will be created with simple randomization in randomization.The data were obtained from the socio-demographic characteristics form and the sleep pattern form developed by the researcher. will be collected with
Detailed description
The aim of this study is to determine the effect of the therapeutic touch applied to the sleep patterns of individuals aged 65-85 years with chronic diseases who are treated in the Neurology Intensive Care Unit of Ankara City Hospital, taking into account the circadian cycle.Research Hospitalization in Ankara City Hospital Neurology Intensive Care It will be done with individuals who have chronic diseases in the 65-85 age range. Research It is planned to be held between November 2021 and December 2022.Therapeutic touch will be applied to the patients selected in the experimental and control groups among the patients who meet the research criteria in the intensive care units. After this application, the sleep pattern changes in the patients will be evaluated.Therapeutic touch will be applied to the patients selected in the experimental and control groups among the patients who meet the research criteria in the intensive care units. After this application, sleep pattern changes in patients will be evaluated. In the analysis of the research, dependent groups t test andindependent groups t test, Mann Whitney U and Kruskal Wallis tests will be used in non-parametric cases
Interventions
OTHERtherapeutic touch
Therapeutic Touch (TT) is an evidence-based holistic treatment method in which universal energy is used intentionally and with compassion for a specific purpose, in order to contribute to one's balance and recovery.In a world dominated by technology, one can lose touch with our inner self. We lose our intuitive abilities for beautiful everyday sensations of nature, the surrounding environment, and various visual and auditory elements. The Therapeutic Touch is an ancient Ayurvedic self-massage technique that connects your body to your soul.It is also used in therapeutic communication. Therapeutic communication is the process of influencing and being influenced by one another. It consists of individual-centered, purposeful, planned, effective and satisfying actions.
Sponsors
KTO Karatay University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
65 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Being in the age range of 65-85 years * Having a Chronic Disease * The patient is receiving treatment at the hospital
Exclusion criteria
* Not in the age range of 65-85 years * Not being able to communicate (being intubated, having hearing impairment, etc.)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analogue Scale | pretest (Measurements taken during the initial consultation) | The Visual Analogue Scale - Anxiety Subtest (VAS-Anxiety) was used to measure anxiety levels. Scores ranged from 0 to 100, where 0 represents no anxiety and 100 represents the highest possible anxiety. Higher scores indicate a worse outcome. Patients marked their anxiety level on the scale, and this score was recorded as the outcome measure. |
| Comparison of Sleep Duration and Sleep Onset Difficulties by Group at Measurement Times (Sleep Duration) | pretest (Measurements taken during the initial consultation) | In this measurement, the sleep duration was recorded as subjective data by the researcher. (Calculated based on the intended bedtime and wake-up time) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analogue Scale | posttest (three weeks after the pre-test) | The Visual Analogue Scale - Anxiety Subtest (VAS-Anxiety) was used to measure anxiety levels. Scores ranged from 0 to 100, where 0 represents no anxiety and 100 represents the highest possible anxiety. Higher scores indicate a worse outcome. Patients marked their anxiety level on the scale, and this score was recorded as the outcome measure. |
| Comparison of Sleep Duration and Sleep Onset Difficulties by Group at Measurement Times (Sleep Duration) | posttest (three weeks after the pre-test) | In this measurement, the sleep duration was recorded as subjective data by the researcher. (Calculated based on the intended bedtime and wake-up time) |
Countries
Turkey (Türkiye)
Contacts
PRINCIPAL_INVESTIGATORBerna Bayır
KTO Karatay University
Participant flow
Recruitment details
The population of the study consisted of 368 patients aged 65-85 years who applied to the clinic within one year. The sample size of the study was calculated by G-power analysis. The sample consisted of 68 patients, 34 in the experimental group and 34 in the control group.
Pre-assignment details
Inclusion Criteria; Between 65 and 85 years of age according to the WHO classification of 1998, The patient was hospitalised in the orthopaedics and traumatology service for at least seven days, The patient is able to communicate. Exclusion Criteria; The presence of a hearing impairment, Intubation, In the acute pain period
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Continuous | 70.50 years STANDARD_DEVIATION 4.84 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) White | 68 Participants |
| Sex: Female, Male Female | 25 Participants |
| Sex: Female, Male Male | 9 Participants |
| Total Count of Participants | 68 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 34 | 0 / 34 |
| other Total, other adverse events | 0 / 34 | 0 / 34 |
| serious Total, serious adverse events | 0 / 34 | 0 / 34 |
Outcome results
None listed